Article info

Download PDFPDF

Original research
Safety and immunogenicity of novel 5T4 viral vectored vaccination regimens in early stage prostate cancer: a phase I clinical trial

Authors

  1. Correspondence to Dr Irina Redchenko; irina.redchenko{at}ndm.ox.ac.uk
View Full Text

Citation

Cappuccini F, Bryant R, Pollock E, et al
Safety and immunogenicity of novel 5T4 viral vectored vaccination regimens in early stage prostate cancer: a phase I clinical trial

Publication history

  • Accepted May 26, 2020
  • First published June 25, 2020.
Online issue publication 
June 25, 2020

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.